Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-106,160
Closed -$2.68M 989
2023
Q3
$2.68M Buy
106,160
+5,875
+6% +$134K 0.02% 282
2023
Q2
$2.12M Buy
+100,285
New +$1.9M 0.02% 298
2022
Q2
Sell
-122,204
Closed -$2.87M 1064
2022
Q1
$2.87M Sell
122,204
-14,790
-11% -$344K 0.03% 165
2021
Q4
$3.73M Buy
+136,994
New +$3.92M 0.04% 168
2021
Q2
Sell
-186,428
Closed -$6.35M 910
2021
Q1
$6.35M Buy
186,428
+3,000
+2% +$115K 0.06% 162
2020
Q4
$6.11M Buy
+183,428
New +$6.7M 0.07% 165
2019
Q2
Sell
-187,286
Closed -$5.44M 892
2019
Q1
$5.44M Buy
187,286
+9,125
+5% +$236K 0.04% 154
2018
Q4
$2.34M Buy
178,161
+41,828
+31% +$667K 0.02% 204
2018
Q3
$2.76M Buy
136,333
+25,931
+23% +$586K 0.02% 212
2018
Q2
$2.61M Buy
110,402
+7,650
+7% +$197K 0.02% 209
2018
Q1
$2.31M Buy
102,752
+17,881
+21% +$471K 0.02% 201
2017
Q4
$2.65M Buy
+84,871
New +$2.51M 0.02% 178
2016
Q4
Sell
-78,884
Closed -$1.15M 721
2016
Q3
$1.15M Sell
78,884
-8,042
-9% -$101K 0.01% 215
2016
Q2
$857K Buy
+86,926
New +$1.01M 0.01% 210
2015
Q2
Sell
-24,619
Closed -$512K 686
2015
Q1
$512K Buy
+24,619
New +$434K ﹤0.01% 535

Other funds holding INSM

ALPS Advisors's INSM Position: Q4 2023 in Review

ALPS Advisors sold out of Insmed (INSM) in Q4 2023, closing a stake of 106,160 shares — an estimated $2.68M sold.

ALPS Advisors first reported a position in INSM in Q1 2015 and held it in 15 quarters. The position peaked at $6.35M in Q1 2021. 271 funds tracked by Wall St. Rank hold INSM as of Q4 2023.

  • ALPS Advisors reported no remaining Insmed position as of Q4 2023 after selling out during the quarter.
  • ALPS Advisors sold 106,160 Insmed shares in Q4 2023, an estimated $2.68M.
  • ALPS Advisors first reported a position in Insmed in Q1 2015 and held it in 15 quarters.
  • ALPS Advisors's Insmed position peaked at $6.35M in Q1 2021.
  • 271 funds tracked by Wall St. Rank held Insmed as of Q4 2023.

Based on ALPS Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.